Buy GMR Infra with stoploss of Rs 165: Arihant

Arihant Capital Market is bullish on GMR Infra and has advised traders to buy the stock with stoploss of Rs 165. "On the daily charts, GMR Infra is in buy on RSI and its 14-days RSI is currently at 71 (above 50 is consider to be in strong hands). GMR Infra is looking strong on daily chart and has formed a Trend Reversal Pattern on EOD chart. One can buy it at Rs 178 with closing below stoploss of Rs 165 for a target price of Rs 210," said Arihant Capital Market report.

(Source : ET)

Buy IDFC with stoploss of Rs 130: Angel

MUMBAI: Angel Broking is bullish on IDFC and has advised to buy the scrip with stoploss of Rs 130.

"IDFC has given a trend line breakout with rising volumes. Further, it has given a positive crossover on RSI and Stochastic oscillators. Traders can buy this stock above Rs 135 levels with stoploss of Rs 130 for target of Rs 152 for 3-5 trading sessions," said Angel Broking note.

(Source : ET)

Buy Dishman, Target - 230: Hem Sec.

Hem Securities has recommended a buy rating on Dishman Pharmaceuticals & Chemicals with price target of Rs 230 in its May 28, 2009 research report.

“The company is a leader in CRAM business amongst the largest Indian pharmaceutical companies. Moreover, in global crisis and weak economy outlook, the company performance for the financial year ended March 2009 is quite strong. Though promoters have pledged 10.60% share of their holding and 6.44% of total equity capital, the company seems to continue its growth momentum through its high revenue generating base business and seems to be extremely attractive investment opportunity in the Indian Pharmaceutical space.”

“Presently, the stock is trading at Rs 184.35 which is at 10.14 times to its earnings of FY09 of Rs 18.18 and 2.65 times to its book value of Rs 69.59. Since the stock offers good investment opportunity, we ini-tiate a ‘BUY’ signal on the stock with a target price of Rs 230 in medium to long term investment horizon expecting an appreciation of about 25% from the current level of Rs 184.35,” says Hem’s research report.”